Your browser doesn't support javascript.
loading
A phase II study of palbociclib plus letrozole plus trastuzumab as neoadjuvant treatment for clinical stages II and III ER+ HER2+ breast cancer (PALTAN).
Ademuyiwa, Foluso O; Northfelt, Donald W; O'Connor, Tracey; Levine, Ellis; Luo, Jingqin; Tao, Yu; Hoog, Jeremy; Laury, Marie L; Summa, Tracy; Hammerschmidt, Trish; Guo, Zhanfang; Frith, Ashley; Weilbaecher, Katherine; Opyrchal, Mateusz; Aft, Rebecca; Clifton, Katherine; Suresh, Rama; Bagegni, Nusayba; Hagemann, Ian S; Iglesia, Michael D; Ma, Cynthia X.
Afiliação
  • Ademuyiwa FO; Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA. bisiademuyiwa@wustl.edu.
  • Northfelt DW; Department of Medical Oncology, Mayo Clinic, Phoenix, AZ, 85054, USA.
  • O'Connor T; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, 14263, USA.
  • Levine E; Department of Medicine, Roswell Park Cancer Institute, Buffalo, NY, 14263, USA.
  • Luo J; Siteman Cancer Center Biostatistics Shared Resource, Washington University School of Medicine, St Louis, MO, 63110, USA.
  • Tao Y; Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO, 63110, USA.
  • Hoog J; Siteman Cancer Center Biostatistics Shared Resource, Washington University School of Medicine, St Louis, MO, 63110, USA.
  • Laury ML; Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, MO, 63110, USA.
  • Summa T; Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA.
  • Hammerschmidt T; Genome Technology Access Center at the McDonnell Genome Institute at Washington University School of Medicine, St. Louis, MO, 63110, USA.
  • Guo Z; Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA.
  • Frith A; Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA.
  • Weilbaecher K; Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA.
  • Opyrchal M; Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA.
  • Aft R; Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA.
  • Clifton K; Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA.
  • Suresh R; Department of Surgery, Washington University School of Medicine, St. Louis, MO, 63110, USA.
  • Bagegni N; Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA.
  • Hagemann IS; Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA.
  • Iglesia MD; Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, 63110, USA.
  • Ma CX; Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO, 63110, USA.
NPJ Breast Cancer ; 9(1): 1, 2023 Jan 06.
Article em En | MEDLINE | ID: mdl-36609389

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2023 Tipo de documento: Article